Quality and stability of oral extemporaneous formulations developed from commercial tablets containing spironolactone

Quality and stability of oral extemporaneous formulations developed from commercial tablets containing spironolactone

Show other versions (1)

The purpose of this study was to develop extemporaneous liquid pharmaceutical formulations from commercial tablets containing spironolactone and to assess their stability for use in children or adults with difficulty in swallowing. The content and stability of spironolactone in the tablets, as...

Full description

Bibliographic Details
Main Authors:	Aline Marques Rosa, Mirella Carla Galana Gerlin, Isabella Correa Alcântara, Rubia Adrieli Sversut, Teófilo Fernando Mazon Cardoso, Patrik Oening Rodrigues, Marcos Serrou do Amaral, Nájla Mohamad Kassab
Format:	Article
Language:	English
Published:	São Paulo State University (UNESP) 2014-08-01
Series:	Revista de Ciências Farmacêuticas Básica e Aplicada
Subjects:	Pediatrics Liquid chromatography Extemporaneous formulations Edema Hypertension and Dispersion
Online Access:	http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/385/1603

Similar Items

Quality and stability of oral extemporaneous formulations developed from commercial tablets containing spironolactone
by: Aline Marques Rosa, et al.
Published: (2014-07-01)

Stability data of extemporaneous suspensions of hydroxychloroquine sulphate in oral liquid bases after tablet manipulation
by: Mara Perrone, et al.
Published: (2020-12-01)

EVALUATION OF THE STABILITY OF VIGABATRIN IN HOSPITALAR EXTEMPORANEOUS FORMULATIONS
by: Marcio Vinicius Ayres, et al.
Published: (2019-07-01)

Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan
by: Musko Monika, et al.
Published: (2014-12-01)

Stability of Extemporaneously Prepared Captopril Solution
by: Park, Sean, et al.
Published: (2012)

The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia
by: Olga Kiseļova, et al.
Published: (2019-08-01)

Labelling of stock preparations and extemporaneous drugs: National and international legislation and practices
by: Vuleta Gordana, et al.
Published: (2014-01-01)

EXTEMPORANEOUS MANUFACTURING OF INTRAVENOUS ADMIXTURES IN HOSPITAL PHARMACIES OF RUSSIAN FEDERATION
by: G. N. Kovalskaya, et al.
Published: (2017-09-01)

Extemporaneous compounding for the drugs that may be used in COVID-19 treatment
by: Jhohann Richard de Lima Benzi
Published: (2020-04-01)

Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA
by: Olga Kiseļova, et al.
Published: (2020-01-01)

A Drug Content, Stability Analysis, and Qualitative Assessment of Pharmacists’ Opinions of Two Exemplar Extemporaneous Formulations
by: Melissa Kirkby, et al.
Published: (2020-07-01)

Extemporaneous Compounding Practice for Dermatologic Preparations in Ethiopian Public Hospitals: Regulatory Requirements and Quality Concerns
by: Selam MN, et al.
Published: (2021-05-01)

Shelf life study of extemporaneously prepared omeprazole oral suspension
by: Hafiz Antar Makeen, et al.
Published: (2018-01-01)

Analysis and expansion ways of the extemporaneous preparations assortment in the republic of Tajikistan
by: Абдуджаббор Халкуллоевич Валиев, et al.
Published: (2015-11-01)

Development and validation of RP-HPLC method for determination of acetazolamide, furosemide and phenytoin extemporaneous suspensions
by: Warisada Sila-on, et al.
Published: (2016-02-01)

Physicochemical Stability of Extemporaneously Prepared Oral Suspension of Fluconazole 50 mg/mL in SuspendIt™
by: Ip Kendice, et al.
Published: (2018-06-01)

Dosing Accuracy of Oral Extemporaneous Suspensions of Antibiotics: Measuring Procedures and Administration Devices
by: Inês Neves, et al.
Published: (2021-04-01)

USAGE OF FINISHED DOSAGE FORMS IN THE MANUFACTURE OF EXTEMPORANEOUS POWDERS
by: A. V. Belyatskaya, et al.
Published: (2019-01-01)

Availability of oral liquid formulations: Dilemmas in managing children with nephrotic syndrome
by: Chakrant Mothsara, et al.
Published: (2020-01-01)

Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension
by: Lisa Foley, et al.
Published: (2021-01-01)

Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies
by: Hatim S. AlKhatib, et al.
Published: (2019-11-01)

Antibiotic prescribing pattern on extemporaneous compounding suspension in primary health care centers
by: Indri Hapsari, et al.
Published: (2019-10-01)

Studying Problem of Providing Medicines to the Patients with Celiac Disease Based on Pharmaceutical Law
by: V.O. Shapovalova, et al.
Published: (2015-03-01)

Physicochemical stability of three generic brands of metformin in solution
by: Radamés Alemón-Medina, et al.
Published: (2014-07-01)

Some signals of hesitation phenomena in spontaneous English speech
by: Smith, Frederick S.
Published: (2013)

Environmental microbial contaminants in selected retail pharmacies of Sri Lanka
by: A. Thayananthan, et al.
Published: (2021-04-01)

Stability Test in Extemporaneous Preparations: Furosemide Syrup, Spironolactone Suspension and Hydrochlorothiazide Suspension
by: Tanita Thaweethamcharoen, et al.
Published: (2014-01-01)

Evaluation of Pharmaceutical Compounding Training in the Australian Undergraduate Pharmacy Curricula
by: Sam Kosari, et al.
Published: (2020-02-01)

Analysis of the current state and problems of pharmacy production of medicines in UKRAINE
by: A. S. Nemchenko, et al.
Published: (2020-07-01)

Compounding medications in a rural setting: an interprofessional perspective
by: Taylor S, et al.
Published: (2018-04-01)

Validation of a stability-indicating HPLC-UV method for the quantification of acetazolamide in Oral-Mix and Oral-Mix SF
by: Charlotte Gillium, et al.
Published: (2020-01-01)

Yield and grape must quality of the IAC 138-22 ‘Máximo’ submitted to canopy management
by: José Luiz Hernandes, et al.

Orodispersible films (ODF) in individualized therapy
by: Ewelina Łyszczarz, et al.
Published: (2019-12-01)

Development and Preparation of Oral Suspensions for Paediatric Patients – a Challenge for Pharmacists
by: Bruns Cornelia, et al.
Published: (2018-06-01)

Formulation of Peperomia pellucida (L) Kunth extract tablet by modified filler
by: Nanang Yunarto
Published: (2013-07-01)

Formulation of Peperomia pellucida (L) Kunth extract tablet by modified filler
by: Nanang Yunarto
Published: (2013-07-01)

Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness
by: Hamad S Alyami, et al.
Published: (2021-05-01)

Physicochemical equivalence studies of two amlodipine tablet formulations
by: Kecman Sanja, et al.
Published: (2018-01-01)

Compounded medication for patients with rare diseases
by: Marc Dooms, et al.
Published: (2018-01-01)

4-WEEK OPEN-LABEL CONTROLLED RANDOMIZED COMPARATIVE STUDY OF THE INJECTABLE AND TABLETTED FORMULATIONS OF METHOTREXATE IN RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2011-06-01)